GH Stock Analysis: Buy, Sell, or Hold?
GH - Guardant Health, Inc. Common Stock
$128.83
-2.95 (-2.24%)
▼
5d:
-2.12%
30d:
+12.06%
90d:
+51.24%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 29, 2026
Get Alerted When GH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GH shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: GH shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: GH is currently trading at $128.83, which is considered slightly high relative to its 30-day fair value range of $110.74 to $134.61.
Technical Outlook: Technically, GH is showing sideways momentum. Immediate support is located at $118.81, while resistance sits at $134.28.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $141.78 (+10.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GH is showing sideways momentum. Immediate support is located at $118.81, while resistance sits at $134.28.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $141.78 (+10.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$110.74 -
$134.61
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
64.2%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($141.78)
Trading Range Analysis
30-Day Trading Range
$110.74 -
$134.61
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$118.81
Resistance Level
$134.28
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-242.94
Wall Street Target
$141.78
(+10.1%)
Revenue Growth (YoY)
48.3%
Profit Margin
-40.1%
Share & Embed Analysis
Last updated: June 23, 2026 2:22 AM ET
Data refreshes hourly during market hours. Next update: 3:22 AM
Data refreshes hourly during market hours. Next update: 3:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Musa Tariq
SELL
116 shares
2026-04-16
Terilyn J Monroe
SELL
3832 shares
2026-04-06
Musa Tariq
SELL
348 shares
2026-03-18
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 51 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 62 BUY |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$310 | 60 HOLD |
Advanced GH Option Strategies
Professional options setups generated by AI based on today's GH price and gamma walls.
